A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy

•Developed pH-responsive niosomes for DOX and CUR.•Optimized encapsulation efficiency via physicochemical analyses.•Showcased increased anticancer efficacy with co-loaded drugs.•Niosomes selectively target cancer cells, improving therapy.•Highlights potential for advanced, targeted cancer treatments...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of pharmaceutical sciences 2023-12, Vol.191, p.106600-106600, Article 106600
Hauptverfasser:	Saharkhiz, Shaghayegh, Zarepour, Atefeh, Nasri, Negar, Cordani, Marco, Zarrabi, Ali
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer therapy Co-administration Doxorubicin Niosome pH-responsive
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!